-
公开(公告)号:US11472803B2
公开(公告)日:2022-10-18
申请号:US17161201
申请日:2021-01-28
发明人: Henrik Teller , Alexandros Vakalopoulos , Melissa Boultadakis Arapinis , Alexander Straub , Hanna Tinel , Markus Brechmann , Matthias Beat Wittwer , Maximillian Andreas Kullmann , Till Freudenberger , Thomas Mondritzki , Tobias Marquardt
IPC分类号: C07D471/04 , A61P9/06 , A61K31/4375 , A61K31/551 , A61K45/06 , C07D491/107 , C07D519/00 , A61P9/00 , A61P13/00
摘要: The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
-
公开(公告)号:US10526314B2
公开(公告)日:2020-01-07
申请号:US16098202
申请日:2017-05-02
发明人: Marie-Pierre Collin-Kröpelin , Peter Kolkhof , Thomas Neubauer , Chantal Fürstner , Elisabeth Pook , Matthias Beat Wittwer , Carsten Schmeck , Pierre Wasnaire , Hanna Tinel , Heiko Schirmer
IPC分类号: C07D401/14 , C07D403/14 , C07D417/14 , A61P9/10 , A61P9/12 , A61P13/12 , A61K31/4196 , A61K31/427 , A61K31/4439 , A61K31/497 , A61K31/501 , A61K45/06
摘要: The present invention relates to novel 5-(hydroxyalkyl)-1-heteroaryl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.
-
公开(公告)号:US10927109B2
公开(公告)日:2021-02-23
申请号:US16333079
申请日:2017-09-06
发明人: Henrik Teller , Alexandros Vakalopoulos , Melissa Boultadakis Arapinis , Alexander Straub , Hanna Tinel , Markus Brechmann , Matthias Beat Wittwer , Maximilian Andreas Kullmann , Till Freudenberger , Thomas Mondritzki , Tobias Marquardt
IPC分类号: C07D471/04 , A61K31/4375 , A61P9/06 , A61K31/551 , A61K45/06 , C07D491/107 , C07D519/00 , A61P9/00 , A61P13/00
摘要: The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
-
公开(公告)号:US11298367B2
公开(公告)日:2022-04-12
申请号:US16758742
申请日:2018-10-17
发明人: Marie-Pierre Collin-Kroepelin , Peter Kolkhof , Thomas Neubauer , Chantal Fuerstner , Elisabeth Pook , Matthias Beat Wittwer , Carsten Schmeck , Pierre Wasnaire , Heiko Schirmer , Hana Cernecka , Karoline Droebner , Hanna Tinel , Anja Buchmueller , Thomas Mondritzki , Axel Kretschmer , Klemens Lustig , Robert Fricke , Guillaume Levilain , Ursula Krenz , Norbert Witowski
IPC分类号: A61K31/675 , A61P13/12 , A61K45/06 , C07F9/6558
摘要: The present invention relates to prodrugs of 3-({3-(4-chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl ]-4,5-dihydro-1H-1,2,4-triazol-1-yl}methyl)-1-[3-(trifluoromethyl)-pyridin-2-yl ]-1H-1,2,4-triazole-5-carboxamide, 3-({3-(4-chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl ]-4,5-dihydro-1H-1,2,4-triazol-1-yl}methyl)-1-[2-(trifluoromethyl)-phenyl]-1H-1,2,4-triazole-5-carboxamide and 3-({3-(4-chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl ]-4,5-dihydro-1H-1,2,4-triazol-1-yl}methyl)-1-(3-chloropyridin-2-yl)-1H-1,2,4-triazole-5-carboxamide, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.
-
公开(公告)号:US11173151B2
公开(公告)日:2021-11-16
申请号:US16756623
申请日:2018-10-17
发明人: Marie-Pierre Collin-Kroepelin , Peter Kolkhof , Thomas Neubauer , Chantal Fuerstner , Elisabeth Pook , Matthias Beat Wittwer , Klemens Lustig , Hanna Tinel , Niels Lindner , Heiko Schirmer
IPC分类号: A61K31/4439 , A61K31/4188 , A61K31/4196 , A61K31/496 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K45/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/10
摘要: The present invention relates to novel substituted 1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.
-
公开(公告)号:US10519154B2
公开(公告)日:2019-12-31
申请号:US16317322
申请日:2017-07-04
发明人: Henrik Teller , Melissa Boultadakis Arapinis , Alexandros Vakalopoulos , Anne-Sophie Rebstock , Alexander Straub , Hanna Tinel , Markus Brechmann , Matthias Beat Wittwer , Maximillian Andreas Kullmann , Klaus Münter , Thomas Mondritzki , Tobias Marquardt
IPC分类号: C07D471/04 , A61P9/06 , A61P13/12 , A61P9/04
摘要: The present application relates to novel 7-substituted 1-pyridylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
-
公开(公告)号:US10435403B2
公开(公告)日:2019-10-08
申请号:US15735138
申请日:2016-06-06
发明人: Henrik Teller , Alexander Straub , Markus Brechmann , Thomas Müller , Mark Meininghaus , Katrin Nowak-Reppel , Hanna Tinel , Klaus Münter , Daniela Fliegner , Thomas Mondritzki , Melissa Boultadakis Arapinis , Tobias Marquardt , Alexandros Vakalopoulos , Anne-Sophie Rebstock , Matthias Beat Wittwer
IPC分类号: C07D471/04 , A61P9/04 , A61K31/4375 , A61K31/4545 , A61K31/496 , A61K31/513 , A61K31/5377 , A61K45/06 , C07D519/00
摘要: The present application relates to positive allosteric modulators of the muscarinic M2 receptor, especially to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of cardiovascular disorders and/or renal disorders.
-
公开(公告)号:US10053428B2
公开(公告)日:2018-08-21
申请号:US15600132
申请日:2017-05-19
发明人: Michael Hahn , Markus Follmann , Eva-Maria Becker , Johannes-Peter Stasch , Joerg Keldenich , Martina Delbeck , Hanna Tinel , Frank Wunder , Joachim Mittendorf , Ildiko Terebesi , Dieter Lang , René Martin , Walter Hübsch
IPC分类号: A61K31/4706 , C07D215/48 , C07D217/26 , C07D401/12 , C07D413/12 , A61K31/4709 , A61K45/06 , A61K31/47
CPC分类号: C07D215/48 , A61K31/47 , A61K31/4706 , A61K31/4709 , A61K45/06 , C07D217/26 , C07D401/12 , C07D413/12
摘要: The present application relates to novel 5-amino-5,6,7,8-tetrahydroquinoline-2-carboxylic acids, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular and cardiopulmonary disorders.
-
公开(公告)号:US20150148340A1
公开(公告)日:2015-05-28
申请号:US14399945
申请日:2013-05-03
发明人: Chantal Fürstner , Jens Ackerstaff , Alexander Straub , Heinrich Meier , Hanna Tinel , Katja Zimmermann , Adrian Tersteegen , Dmitry Zubov , Raimund Kast , Jens Schamberger , Martina Schäfer , Kirsten Börngen
IPC分类号: C07D417/14 , A61K31/513 , C07D405/14 , A61K45/06 , C07D417/04 , C07D401/04 , C07D409/14 , C07D403/04 , C07D413/04
CPC分类号: A61K31/513 , A61K31/506 , A61K31/536 , A61K31/538 , A61K45/06 , C07D401/04 , C07D403/04 , C07D405/14 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/14 , C07D471/04
摘要: The present application relates to novel bicyclically substituted uracil derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases.
摘要翻译: 本申请涉及新颖的双环取代的尿嘧啶衍生物,其制备方法,单独使用或组合用于治疗和/或预防疾病,以及其用于生产用于治疗和/或预防 疾病
-
公开(公告)号:US11230540B2
公开(公告)日:2022-01-25
申请号:US16758744
申请日:2018-10-17
发明人: Marie-Pierre Collin-Kroepelin , Peter Kolkhof , Thomas Neubauer , Chantal Fuerstner , Elisabeth Pook , Hanna Tinel , Carsten Schmeck , Pierre Wasnaire , Heiko Schirmer , Klemens Lustig
IPC分类号: C07D403/14 , A61P9/10 , A61K45/06 , C07D401/14 , C07D403/06 , C07D405/14 , C07D413/14
摘要: The present invention relates to novel substituted 1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.
-
-
-
-
-
-
-
-
-